Real-time Activity Monitoring to Prevent Admissions During RadioTherapy
RAMPART
1 other identifier
interventional
40
1 country
1
Brief Summary
This study will aim to demonstrate that implementation of a rapid, multidisciplinary supportive care program for patients receiving chemoradiotherapy who are deemed to be at high risk for hospitalization based on real-time pedometer data will reduce the rate of hospitalization during chemoradiotherapy or within four weeks of radiotherapy completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
April 5, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedApril 13, 2026
April 1, 2026
8 months
January 23, 2017
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients hospitalized during treatment or within 4 weeks after completing radiotherapy.
The primary endpoint of this study is hospitalization during chemoradiotherapy or within 4 weeks after completion of radiotherapy.
During chemoradiotherapy or within 4 weeks after completion of radiotherapy.
Secondary Outcomes (7)
Activation of the enhanced supportive care protocol
During chemoradiotherapy or within 4 weeks after completion of radiotherapy.
Frequency of clinician visits and supportive care measures implemented.
During chemoradiotherapy or within 4 weeks after completion of radiotherapy
Patient-reported quality of life scores
During chemoradiotherapy or within 4 weeks after completion of radiotherapy.
Treatment-related toxicities
During chemoradiotherapy or within 4 weeks after completion of radiotherapy.
Disease status
During chemoradiotherapy and up to two years after completion of radiotherapy.
- +2 more secondary outcomes
Study Arms (1)
Activity Monitoring
EXPERIMENTAL1. Enhanced Supportive Care - Status Checks Would occur everyday during treatment when a patient is deemed high-risk based on activity level. Other Names: •Daily Status Checks 2. Enhanced Supportive Care - Referrals On an as-need basis, high risk patients can be referred to our nutritionist or palliative care doctor. Other Names: •Referrals
Interventions
Would occur everyday during treatment when a patient is deemed high-risk.
On an as-need basis, high risk patients can be referred to our nutritionist or palliative care doctor.
Eligibility Criteria
You may qualify if:
- Age \> 18
- ECOG performance status 0-2
- Able to ambulate independently (without the assistance of a cane or walker)
- Diagnosis of invasive malignancy of the head and neck region, lung, esophagus, or stomach
- Planned treatment with fractionated (≥15 treatments) external beam radiotherapy with concurrent chemotherapy (or cetuximab) with curative intent (including preoperative or postoperative treatment)
- Women of childbearing potential must:
- Have a negative serum or urine pregnancy test within 72 hours prior to the start of study therapy
- Agree to utilize an adequate method of contraception throughout treatment and for at least 4 weeks after study therapy is completed
- Be advised of the importance of avoiding pregnancy during trial participation and the potential risks of an unintentional pregnancy
- All patients must sign study specific informed consent prior to study entry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montefiore Medical Center
The Bronx, New York, 10467, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2017
First Posted
April 5, 2017
Study Start
July 1, 2016
Primary Completion
March 1, 2017
Study Completion
September 1, 2017
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share